Alembic Pharmaceuticals Board of Directors

Get the latest insights into the leadership at Alembic Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Chirayu Amin Chairman & CEO
Mr. Pranav Amin Managing Director
Mr. Shaunak Amin Managing Director
Mr. R K Baheti Director - Finance & CFO
Mr. Jai Diwanji Independent Director
Mr. Ashok Barat Independent Director
Ms. Geeta Goradia Independent Director
Mr. Manish Kejriwal Independent Director

Alembic Pharmaceuticals Share price

APLLTD

939

2.05 (0.22%)
NSE
BSE
Last updated on 1 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

950.00

Today's Low

926.00

52 Week Low

725.20

52 Week High

1303.90

The current prices are delayed, login to your account for live prices

Alembic Pharmaceuticals FAQs

The board at Alembic Pharmaceuticals consists of experienced professionals, including Mr. Chirayu Amin , Mr. Pranav Amin , and others, overseeing the company’s strategic and corporate governance.

Directors at Alembic Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Chirayu Amin is the current chairman at Alembic Pharmaceuticals.

Executive directors at Alembic Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Alembic Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Alembic Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.